Clinical Trial Update: Efficacy and Safety of PRO-148 Ophthalmic Solution Versus SYSTANE® in the Treatment of Patients With Dry Eye Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial comparing PRO-148 ophthalmic solution to SYSTANE in dry eye syndrome; results completed and posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Syndrome

Drugs mentioned

• PRO-148 ophthalmic solution (PRO-148 ophthalmic solution)
• Systane

Snippet

Sponsor: Laboratorios Sophia S.A de C.V. | Conditions: Dry Eye Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2018-10-30